SCHEMBL6513739

SCHEMBL6513739

Cc1nc(NC(N)=Nc2cccc(Cc3ccccc3)c2)nc2c1CCCC2

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 5/20 0.42
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
LMNA P02545 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
SIGMAR1 Q99720 5/20 0.41
GRIN2D O15399 2/20 0.41
GRIN3B O60391 2/20 0.41
GRIN1 Q05586 2/20 0.41
GRIN2A Q12879 2/20 0.41
GRIN2B Q13224 2/20 0.41
GRIN2C Q14957 2/20 0.41
GRIN3A Q8TCU5 2/20 0.41
MAPT P10636 4/20 0.41
POLB P06746 1/20 0.39
ADRA2A P08913 1/20 0.38
KDM4E B2RXH2 1/20 0.37
MEN1 O00255 1/20 0.37
GFER P55789 1/20 0.37
KMT2A Q03164 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6509392 0.86 MAPT (0.43) SMN1; SMN2NPC1RAB9ALMNAL3MBTL1
SCHEMBL6508660 0.85 MAPK1 (0.52) SMN1; SMN2NPC1RAB9ALMNAL3MBTL1
SCHEMBL6510588 0.81 LMNA (0.50) SMN1; SMN2NPC1RAB9ALMNASIGMAR1
SCHEMBL6507347 0.81 LMNA (0.52) SMN1; SMN2NPC1RAB9ALMNASIGMAR1
SCHEMBL6511304 0.81 MAPT (0.45) SMN1; SMN2NPC1RAB9ALMNAL3MBTL1
SCHEMBL5922994 0.78 SMN1; SMN2 (0.43) SMN1; SMN2NPC1RAB9ALMNAL3MBTL1
SCHEMBL6508617 0.76 SIGMAR1 (0.46) SIGMAR1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL6507985 0.76 NPC1 (0.47) SMN1; SMN2NPC1RAB9AL3MBTL1SIGMAR1
SCHEMBL6507406 0.74 RAB9A (0.52) SMN1; SMN2NPC1RAB9ALMNASIGMAR1
SCHEMBL4100977 0.73 SIGMAR1 (0.55) SMN1; SMN2LMNAL3MBTL1SIGMAR1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005095345-A2 HETEROARYL GUANIDINES AS INHIBITORS OF VIRAL REPLICATION ACHILLION PHARMACEUTICALS, INC. (US) 2005-10-13 WO claimed